Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology

ClinicalTrials.gov ID: NCT03294941

Public ClinicalTrials.gov record NCT03294941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The HepQuant SHUNT test, which is provided as a HepQuant SHUNT Liver Diagnostic Kit, is a minimally-invasive test of liver function and physiology which has been designated by the FDA as an investigational drug/device combination product. Enrollment into one of the 3 Gilead Selonsertib clinical trials (GS-US-416-2124, GS-US-384-1943/1944) is required for enrollment into the HepQuant study

Study identification

NCT ID
NCT03294941
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
HepQuant, LLC
Industry
Enrollment
17 participants

Conditions and interventions

Interventions

Combination Product

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2017 (Actual)
Primary completion
Sep 11, 2019 (Actual)
Completion
Sep 11, 2019 (Actual)
Last update posted
Aug 9, 2021

2017 – 2019

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
Schiff Center for Liver Diseases Miami Florida 33136 —
University of PA Philadelphia Pennsylvania 19104 —
Methodist Dallas Medical Center Dallas Texas 75203 —
TX Digestive Disease Consultants Dallas Texas 76092 —
The Texas Liver Institute San Antonio Texas 78215 —
McGuire VA Med Cntr Richmond Virginia 23224 —
Virginia Commonwealth University Richmond Virginia 23298 —
University of Washingtion Seattle Washington 98103 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03294941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2021 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03294941 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →